Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Dayu Pharmaceutical is a comprehensive pharmaceutical enterprise based in Wuhan, China, specializing in the research, development, and large-scale production of chemical drugs and traditional Chinese medicines. Established in 1988, the company operates advanced GMP-certified manufacturing facilities that produce a wide range of dosage forms, including tablets, capsules, and injections. Its product portfolio primarily focuses on therapeutic areas such as cardiovascular health, metabolic diseases, and anti-infectives, featuring well-known generic medications like nifedipine and metformin. As a recognized high-tech enterprise in Hubei Province, Wuhan Dayu Pharmaceutical is dedicated to maintaining high quality standards and expanding its footprint in the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Dayu Pharmaceutical.